Current status of CD34+ cell analysis by flow cytometry: The ISHAGE guidelines
- 31 March 1997
- journal article
- review article
- Published by Elsevier in Clinical Immunology Newsletter
- Vol. 17 (2-3) , 21-29
- https://doi.org/10.1016/s0197-1859(97)81348-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Response to Letter to the Editor: Re: QBEnd10 (CD34) Antibody Is Unsuitable for Routine Use in the ISHAGE CD34+ Cell Determination AssayJournal of Hematotherapy, 1996
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- North American Multicenter Study on Flow Cytometric Enumeration of CD34+ Hematopoietic Stem CellsJournal of Hematotherapy, 1996
- Immunophenotyping of Acute Leukemia by Flow Cytometric Analysis:Use of CD45 and Right-Angle Light Scatter to Gate on Leukemic Blasts in Three-Color AnalysisAmerican Journal of Clinical Pathology, 1993
- Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization—Mulhouse, France, February 6-8 and 14-15, 1992Journal of Hematotherapy, 1992
- The CD34 Antigen: Structure, Biology, and Potential Clinical ApplicationsJournal of Hematotherapy, 1992
- Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaBlood, 1991
- The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]Blood, 1991
- Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patientsBlood, 1991
- Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factorBlood, 1989